Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
desktop iconMarkt Monitor

BioPharma« Terug naar discussie overzicht

GTCB - GTC Biotherapeutics - Deel 3

1.039 Posts
Pagina: «« 1 ... 44 45 46 47 48 ... 52 »» | Laatste | Omlaag ↓
  1. [verwijderd] 13 september 2006 17:06
    quote:

    tim670 schreef:

    Sorry jongens,

    dit was niet mijn bedoeling.
    Maar tot welke streken die MM's in staat zijn, hebben we ondertussen al genoeg meegemaakt denk ik, niet ?

    Groeten
    maakt niet uit, iedere rare dip is gewoon blind kopen, eerder dit jaar ook wat gespeel met de koers inderdaad

    ben erg benieuwd naar de volgende insitutional ownership tabel van 30 september (zien we pas in november dan), die zal er leuk uit gaan zien, ook gezien de plaatsing erg benieuwd naar de verdeling en evt nieuwe namen

    EU approval blijft overeind en EU data gaat bij de US fda data, dus veel minder kans op afwijzing ivm te weinig data voor de fda..
  2. [verwijderd] 13 september 2006 17:22
    quote:

    M.A.D.W. schreef:

    [quote=ramon72]
    Noem mij eens èèn reden waarom de beurzen verder zouden moeten zakken? Het ene na het andere bedrijf weet betere resultaten te melden t.o.v het jaar daarvoor.Omdat Israel in conflict is/was met Libanon? kom op zeg dat is nog nooit anders geweest,de overige problematiek idemdito.
    [/quote]

    Omdat amerika een groot probleem heeft. Het land is zo goed als failliet!! De dollar kan nog behoorlijk dalen. De economie in europa begint af te stompen. En zo kan ik nog wel even door gaan met waarom de beurzen omlaag kunnen.
    Tja,de enige bedrijfstak die nergens last van heeft zijn de pharmaceutische bedrijven,geen last van $invloeden,geen last van dure olie,geen last van inflatie,eigenlijk komt het hierop neer,laat de economie naar de kloten gaan,verdienen wij de krenten in de pap.

    Groet.
  3. [verwijderd] 13 september 2006 17:29

    voorlopig niks te horen van Merrimack Pharma

    It has collaborative agreements with Merrimack Pharmaceuticals, Inc.; Cambrex Bio Science Hopkinton; Pharming Group N.V.; Advanced Cell Technologies, Inc.; Tufts University School of Veterinary Medicine; and Elan
    news.tradingcharts.com/futures/9/9/82...
  4. [verwijderd] 13 september 2006 19:54
    wish is er niks te doen op het isotis forumpje

    quote:

    wishdom schreef:

    1,21 ( 18:43 ) 0,01 / 0,83%


    Laatste volume 100
    Volume 32.322

    Slot 1,20 12-9-2006
    Open 1,20 15:46
    Hoog 1,21 15:46
    Laag 1,20 15:56

    Pppfff weinig handel,voorkennis? of nee,misschien een PB,shit een PB,tja sorry hoor maar kom net bij Pharming.

    Groet,Hahahahahaha.
  5. [verwijderd] 13 september 2006 20:06
    quote:

    The Wishbone schreef:

    wish is er niks te doen op het isotis forumpje

    [quote=wishdom]
    1,21 ( 18:43 ) 0,01 / 0,83%


    Laatste volume 100
    Volume 32.322

    Slot 1,20 12-9-2006
    Open 1,20 15:46
    Hoog 1,21 15:46
    Laag 1,20 15:56

    Pppfff weinig handel,voorkennis? of nee,misschien een PB,shit een PB,tja sorry hoor maar kom net bij Pharming.

    Groet,Hahahahahaha.
    [/quote]
    Nee Wish,momenteel weinig te beleven,om eerlijk te zijn nergens eigenlijk.
    Denk dat alles wel gezegt is.

    Misschien kan je de betaalsite verder uitwerken.

    Groet.
  6. [verwijderd] 13 september 2006 22:26
    Allemaal kleine spelers...omzet net 100k...

    21:59:29 1,2000 595
    21:59:06 1,2100 400
    21:58:32 1,2100 300
    21:57:47 1,2000 100
    21:55:10 1,2000 143
    21:55:02 1,2000 200
    21:51:46 1,2000 3200
    21:51:46 1,2000 300
    21:51:43 1,2100 100
    21:46:22 1,2100 100
    21:41:02 1,2100 100
    21:37:56 1,2100 100
    21:36:55 1,2000 300
    21:32:37 1,2100 300
    21:32:10 1,2000 1543
    21:32:10 1,2000 1800
    21:32:10 1,2000 407
    21:32:10 1,2000 500
    21:32:10 1,2000 4100
    21:32:10 1,2000 100
    21:32:10 1,2000 100
    21:32:10 1,2000 100
    21:32:10 1,2000 100
    21:32:08 1,2100 4150
    21:32:08 1,2100 200
    21:32:08 1,2100 500
    21:32:08 1,2100 400
    21:32:08 1,2100 200
    21:32:08 1,2100 500
    21:32:08 1,2100 100
    21:25:03 1,2100 100
    21:25:03 1,2100 200
    21:25:03 1,2100 400
    21:25:03 1,2100 200
    21:25:02 1,2100 200
    21:24:48 1,2200 100
    21:24:48 1,2200 158
    21:24:47 1,2200 625
    21:24:47 1,2100 100
    21:24:47 1,2100 100
    21:24:47 1,2100 100
    21:24:47 1,2100 100
    21:24:47 1,2100 100
    21:24:47 1,2100 100
    21:24:47 1,2100 100
    21:24:47 1,2100 100
    21:24:47 1,2100 100
    21:14:26 1,2100 300
    21:13:55 1,2100 200
    21:09:48 1,2000 700
    21:09:47 1,2100 500
    21:05:46 1,2000 1400
    21:05:46 1,2100 1300
    21:05:46 1,2100 100
    21:05:46 1,2100 200
    21:02:49 1,2200 1300
    20:48:44 1,2108 500
    20:48:38 1,2200 1000
    20:48:25 1,2200 100
    20:48:05 1,2200 100
    20:20:36 1,2100 100
    20:16:31 1,2200 200
    20:14:57 1,2178 600
    20:14:17 1,2200 165
    19:53:53 1,2200 100
    19:49:37 1,2200 100
    19:49:37 1,2200 100
    19:46:52 1,2100 100
    19:46:52 1,2100 100
    19:46:52 1,2100 175
    19:46:52 1,2100 100
    19:46:52 1,2100 100
    19:46:52 1,2100 100
    19:46:52 1,2100 200
    19:46:52 1,2100 100
    19:46:52 1,2100 100
    19:46:52 1,2100 1225
    19:46:52 1,2100 500
    19:46:52 1,2100 100
    19:46:52 1,2100 100
    19:46:52 1,2100 100
    19:29:28 1,2114 130
    19:19:00 1,2200 4000
    19:18:01 1,2200 2000
    19:16:54 1,2200 217
    19:09:41 1,2200 1000
    19:05:07 1,2100 200
    19:05:07 1,2100 500
    19:05:07 1,2100 200
    19:05:07 1,2100 200
    19:05:07 1,2100 400
    19:03:12 1,2100 600
    19:03:08 1,2200 2000
    19:02:16 1,2100 100
    19:02:16 1,2100 983
    19:02:16 1,2100 100
    19:02:16 1,2100 100
    19:02:16 1,2100 3000
    19:02:16 1,2100 300
    19:00:59 1,2100 300
    19:00:59 1,2100 3192
    19:00:59 1,2100 600
    19:00:59 1,2100 100
    19:00:59 1,2100 100
    19:00:59 1,2100 300
    19:00:59 1,2100 1000
    19:00:59 1,2100 1000
    19:00:59 1,2100 300
    19:00:59 1,2100 100
    19:00:22 1,2100 100
    18:59:23 1,2091 300
    18:59:23 1,2100 100
    18:59:23 1,2100 400
    18:59:23 1,2100 300
    18:59:23 1,2100 200
    18:59:18 1,2100 100
    18:59:18 1,2100 100
    18:59:12 1,2100 100
    18:59:12 1,2100 100
    18:59:12 1,2100 100
    18:59:12 1,2100 200
    18:59:09 1,2100 100
    18:59:09 1,2100 100
    18:59:09 1,2100 100
    18:59:09 1,2100 100
    18:59:09 1,2100 100
    18:59:09 1,2100 692
    18:59:09 1,2100 100
    18:59:08 1,2100 100
    18:59:08 1,2100 200
    18:59:08 1,2100 200
    18:59:08 1,2100 100
    18:59:08 1,2100 100
    18:59:08 1,2100 2393
    18:59:08 1,2100 115
    18:59:08 1,2100 100
    18:59:08 1,2100 100
    18:59:08 1,2100 200
    18:59:08 1,2100 100
    18:58:50 1,2100 1321
    18:58:21 1,2100 1765
    18:57:45 1,2100 3431
    18:57:43 1,2100 1569
    18:55:24 1,2100 100
    18:46:04 1,2100 100
    18:45:13 1,2100 100
    18:43:12 1,2100 100
    18:39:10 1,2100 152
    18:20:45 1,2000 200
    18:19:29 1,2090 1000
    18:15:11 1,2100 2300
    18:00:29 1,2000 780
    17:56:54 1,2000 1000
    17:50:02 1,2100 100
    17:37:03 1,2100 4000
    17:31:43 1,2100 200
    17:29:52 1,2100 100
    17:23:54 1,2082 1000
    17:13:49 1,2100 200
    17:05:37 1,2100 200
    17:01:22 1,2086 300
    17:00:16 1,2100 100
    17:00:16 1,2100 100
    16:52:35 1,2000 1900
    16:52:35 1,2000 500
    16:52:31 1,2000 100
    16:52:31 1,2000 100
    16:52:30 1,2000 300
    16:52:30 1,2000 100
    16:43:03 1,2010 1000
    16:37:28 1,2000 2000
    16:36:57 1,2090 200
    16:33:57 1,2100 200
    16:23:08 1,2100 100
    16:08:19 1,2000 1000
    16:04:24 1,2000 2750
    16:04:24 1,2000 950
    16:04:24 1,2000 1300
    16:00:41 1,2012 100
    15:56:34 1,2000 6130
    15:56:30 1,2100 200
    15:56:30 1,2100 100
    15:47:20 1,2100 100
    15:46:10 1,2100 100
    15:30:01 1,2000 0
    15:30:01 1,2000 1260
  7. [verwijderd] 13 september 2006 22:36
    Posted by: DewDiligence

    Here’s an indication where it may be beneficial
    to give both antithrombin and intermittent heparin:

    Use of a Novel Anticoagulation Strategy During ECMO in a Pediatric Population: Single-Center Experience
    www.ncbi.nlm.nih.gov/entrez/query.fcg...

    >>
    ASAIO J. 2006 September/October;52(5):513-516.

    Agati S, Ciccarello G, Salvo D, Turla G, Undar A, Mignosa C.

    Cardiac Surgery Unit and Intensive Care Unit, "San Vincenzo" Hospital, Taormina, Italy; Perfusion Service EPS, Taormina, Italy; Tecno Health, Novara, Italy; Departments of Pediatrics, Surgery, and Bioengineering, Penn State College of Medicine, Hershey, Pennsylvania.

    We describe a novel anticoagulation strategy with continuous intravenous antithrombin infusion and intermittent heparin infusion in pediatric population during extracorporeal membrane oxygenation (ECMO).

    From November 2004 through February 2006, 11 patients required ECMO for postcardiotomy cardiorespiratory failure. The mean duration of support time was 112 hours (range 68-192 hours).

    Since April 2005, we modified our anticoagulation protocol in the last six patients. Continuous antithrombin infusion was started immediately after surgery based on the lab result. The antithrombin level was maintained >100% using the following formula:100 (target value) - (Antithrombin value on lab test) x weight in 4 hours.

    Antithrombin value was checked at 4-hour intervals. Heparin infusion was started when the antithrombin value was > 100% and remained stable for more than 12 hours and the amount of bleeding was < 2 ml/kg for more than 3 consecutive hours; then heparin infusion was started at 2 UI/kg/h via the oxygenator (target ACT was not < 150 seconds).

    Three patients in the first group died. Eight patients were weaned and discharged; the third, fourth, and fifth required surgical revision for bleeding. One experienced minor neurologic sequelae.

    Neither surgical revision nor thromboembolic complications occurred in the new anticoagulation group. A novel anticoagulation strategy utilizing continuous intravenous antithrombin and intermittent heparin infusion reduced significantly surgical revision for bleeding in the first 48 hours. This has translated into excellent overall outcomes.

  8. ludwig mack 14 september 2006 16:21
    Last Trade: 1.22
    hoi, plus 2 cent !

    Trade Time: 10:03AM ET
    Change: 0.02 (1.67%)
    Prev Close: 1.20
    Open: 1.21
    Bid: 1.21 x 5000
    Ask: 1.22 x 5400
    1y Target Est: 4.00

    Day's Range: 1.20 - 1.22
    52wk Range: 0.87 - 2.41
    Volume: 5,950
    Avg Vol (3m): 338,282
    Market Cap: 89.60M
    P/E (ttm): N/A
    EPS (ttm): -0.58
    Div & Yield: N/A (N/A)

1.039 Posts
Pagina: «« 1 ... 44 45 46 47 48 ... 52 »» | Laatste |Omhoog ↑